Skip to main content

Language: English / Gàidhlig

Loading…

Seòmar agus comataidhean

Question reference: S6W-17892

  • Date lodged: 11 May 2023
  • Current status: Answered by Jenni Minto on 22 May 2023

Question

To ask the Scottish Government whether it will sign up to Crohn's and Colitis UK's campaign pledges, which are set out on its campaigns website.


Answer

The Scottish Government is committed to ensuring those living with Crohn’s or Colitis are able to access the best possible care and support and that they benefit from healthcare services that are safe, effective and put people at the centre of their care.

Whilst the Scottish Government has not signed the campaign pledges, we continue to support the Crohn’s & Colitis UK campaign for earlier diagnosis. In March 2023 we launched an awareness campaign to help increase awareness of Crohn’s and Colitis symptoms and signpost to reliable information so people feel empowered to seek help from a medical professional when needed. We engaged with Crohn’s & Colitis UK to ensure the campaign was complementary to their own.

We will continue to improve services for people with the condition through the Modernising Patient Pathways Programme (MPPP). MPPP has a specific workstream continuing to promote improvements in Inflammatory Bowel Disease (IBD) care for patients across Scotland in partnership with third sector and people with lived experience. Scotland’s national IBD Steering Group has identified priority areas for work over the next two years. This includes consideration of referral pathways and models of IBD care to drive a more standardised and equitable service across Scotland.

To specifically support scope based diagnostics, such as endoscopy, we have published an Endoscopy and Urology Diagnostic Recovery and Renewal plan backed by £70m. The plan focuses on key areas such as: Balancing Demand and Capacity; Workforce Training and Development; Infrastructure; and Innovation and Redesign. While endoscopy capacity remains challenged, patients referred on our most urgent pathways continue to be prioritised for scope-based diagnostic tests.